DFE Pharma

Do you have questions about continuous manufacturing processes and their implementation? Dr. Sara Fathollahi is a Product Application Specialist at DFE Pharma and an expert in this topic. She holds a Bachelor of Science (BSc) in Biomedical Engineering from Science and Research University of Tehran (Iran), a Master of Science (MSc) in Biomedical Engineering and a Ph.D., Process Engineering from Graz University of Technology (Austria). Get in touch with our expert: https://lnkd.in/eEBwjT6X

One of the biggest challenges that our planet faces today is addressing climate change. DFE Pharma committed to delivering its solutions and products in an environmental friendly manner. We have set an ambition target to reduce our greenhouse gas emissions by 42% in absolute terms. The applied roadmap is in support of the Science-Based Targets initiative for setting 1.5°C aligned goals within its scope 1 and scope 2 and scope 3. Specifically, For our Scope 3 FLAG, we aim for a 30.3% absolute reduction. Our initiatives include focusing on green electricity and developing technical roadmaps for our production sites to improve energy efficiency and transition to sustainable energy sources. For more details, check our ESG report: https://lnkd.in/dSdBxrdD

Biopharma Professionals: Concerned about supply shortage of high purity sucrose or trehalose? BioHale® excipients by DFE Pharma ensure: ✔ Security of Supply: Local availability around the world. ✔ Production Capacity: Ample capacity to meet your needs, diminish risk and prevent extra costs. ✔ Uncompromised quality: high purity, low endotoxin Trust BioHale® for the stabilization of your biologics. Request a sample today: https://lnkd.in/eFA-aBE7

Happy New Year 2025 from DFE Pharma! As we step into a brand-new year, we want to extend our heartfelt gratitude to our partners, customers, and colleagues for your trust and collaboration throughout 2024. This year, we achieved incredible milestones, expanded our capabilities, and strengthened our commitment to shaping the future of healthcare. Together, we’ve made strides in delivering innovative solutions that improve lives globally. Let’s make 2025 another year of innovation, progress, and shared success! Wishing you a prosperous and joyful New Year. #Pharmaceuticals #Excipients

6 decades ago, DFE Pharma played a critical role in the creation and development of Sodium Starch Glycolate (SSG), an excipient extensively used as a superdisintegrant in various drug formulations such as tablets and capsules. Our premium SSG brand, Primojel®, was born in this process. Over the years, our dedicated team at our production facility in Foxhol, the Netherlands, has increased the production capacity of Primojel® and is committed to continuously improving safety standards to ensure the sustained availability of SSG. At Foxhol, our team places paramount value on the overall well-being of its members. In this regard, special days are devoted to fun, educational, and revitalizing activities. These team days are filled with workshops on stress, sustainable employability, nutrition, and the challenges of taking good care of oneself during shifts.

INTO - Inhalation Together offers a single gateway to expertise in the field of Dry Powder Inhalation. With just one touchpoint, you'll have direct access to top companies handling the main components of your DPI product. You'll gain access to a science-based solution that supports every aspect of your formulation, covering all critical stages of the development process. #InhalationTogether #Formulation #inhalation

Expanding Possibilities in Respiratory Health As the demand for innovative respiratory treatments grows, we are proud to announce the expansion of our capabilities at the Closer to the Formulator (C2F) Center to support the development of critical Dry Powder Inhalation (DPI) treatments. Since its launch in September 2022, the C2F Center has been a driving force in accelerating pharmaceutical product development, initially focusing on oral solid dosage forms. Now, we’re building on this success to meet the needs of the evolving respiratory market. 🔹 Why this matters: - Addressing Growing Needs: Enhanced capabilities to support the development of DPI products for the increasing prevalence of respiratory conditions. - World-Class Expertise: Access to state-of-the-art equipment and one of the few labs worldwide with such specialized inhalation expertise. At DFE Pharma, we’re committed to advancing healthcare solutions that improve lives. Interested in partnering with us? Connect with our team: www.dfepharma.com/contact #DPI #Pharmaceuticals #ClosertoTheFormulator

Unlocking the Potential of Continuous Manufacturing: “A Critical Review on the Role of Excipient Properties in Pharmaceutical Powder-to-Tablet Continuous Manufacturing.” This review provides actionable insights to help the pharmaceutical industry optimize processes and formulations for continuous manufacturing. Key takeaways: - In-depth analysis of excipient properties and their impact on various unit operations. - Practical solutions for overcoming challenges in continuous manufacturing. - A roadmap for leveraging excipient properties to enhance process efficiency and product quality. With this comprehensive framework, we aim to empower pharmaceutical innovators to accelerate process optimization and advance the adoption of continuous manufacturing. Explore the article here: https://lnkd.in/dZWWTykX Congratulations to the authors: Dr. Pauline van der Wijst - Janssen, Dr. Sara Fathollahi, Dr. Bastiaan HJ Dickhoff, and Prof. Dr. Henderik W. Frijlink. Let’s shape the future of pharmaceutical manufacturing together! #ContinuousManufacturing #Excipients #Pharmaceuticals

We’re delighted to share our latest research collaboration with Ghent University and GEA Group, now published in Powders Journal: "Understanding Powder Behavior in Continuous Feeding: Powder Densification and Screw Layering." This groundbreaking work tackles critical challenges in continuous pharmaceutical manufacturing, blending material science and big data analysis to optimize processes. Key Insights: - New methodologies for evaluating densification and screw layering in continuous feeding. - Practical guidance for selecting excipients to address feeding challenges. - Strategies to minimize startup times and enhance feeder reliability. - Potential of co-processed excipients in continuous manufacturing. We’re proud to contribute to advancing pharmaceutical manufacturing and would love to explore how these findings could enhance your processes. Read the full paper and discover more: https://lnkd.in/dSPMDCrq Congratulations to the authors: Sara Fathollahi, Pauline van der Wijst - Janssen, Bram Bekaert, Dirk Vanderroost, Valérie Vanhoorne and Bastiaan HJ Dickhoff. #Pharmaceuticals #ContinuousManufacturing #Excipients

Season's Greetings from DFE Pharma! As the year draws to a close, we want to take a moment to express our heartfelt gratitude to our partners, customers, and colleagues across the globe. 2024 has been an incredible journey of innovation, collaboration, and shared achievements. Together, we've worked to advance patient care and enable healthier lives—a mission that inspires everything we do. As we step into this festive season, let us celebrate the connections that make progress possible. From all of us at DFE Pharma, we wish you and your loved ones a joyful holiday season filled with warmth, peace, and prosperity. Here's to a brighter 2025, where we continue to co-create excellence and shape the future of health together!